Dr. William Hancock, the Bradstreet Chair in Chemistry and Chemical Biology and an expert in protein drugs, has been invited to serve as a consultant as a consultant to the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology in the Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration (FDA).

Northeastern professor Barry Karger, whose contributions to analytical chemistry helped enable the sequencing of the human genome, received the Arnold O. Beckman Medal and Award for Outstanding Scientific Achievements in the field of electrodriven separation techniques.

This year marks the 40th anniver­sary of the founding of Northeastern’s Bar­nett Insti­tute of Chem­ical and Bio­log­ical Analysis.

North­eastern University’s Bar­nett Insti­tute of Chem­ical and Bio­log­ical Analysis for­mally announced a tech­nology alliance part­ner­ship with Thermo Fisher Sci­en­tific, a multibillion-​​dollar ana­lyt­ical instru­men­ta­tion and product com­pany, based in San Jose, Calif., with cor­po­rate offices in Waltham, MA.

Biologic drugs represent one of the most important and fastest growing areas in healthcare today, and especially as these biopharmaceuticals begin to come off patent and developers prepare for biosimilars to hit the market, there is a growing need for advanced analytics throughout the drug development process.

Biologic drugs represent one of the most important and fastest growing areas in healthcare today, and especially as these biopharmaceuticals begin to come off patent and developers prepare for biosimilars to hit the market, there is a growing need for advanced analytics throughout the drug development process.